Phenotypic switching of vascular smooth muscle cells in the 'normal region' of aorta from atherosclerosis patients is regulated by miR-145

Journal of Cellular and Molecular Medicine

Volumn 20, Issue 6, 2016, Pages 1049-1061

  Zhang, Yu nan ^a,b   Xie, Bao dong ^a,b   Sun, Lu ^a,b   Chen, Wei ^a,b   Jiang, Shu Lin ^a,b   Liu, Wei ^b   Bian, Fei ^b   Tian, Hai ^a,b   Li, Ren Ke ^c  

^a THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Atherosclerosis; miR 145; Phenotypic switch; Proliferation; VSMCs

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALPONIN; KRUPPEL LIKE FACTOR 5; MICRORNA 145; MYOCARDIN; BIOLOGICAL MARKER; MICRORNA; MIRN145 MICRORNA, HUMAN;

ADULT; ARTICLE; ATHEROSCLEROSIS; CELL PROLIFERATION; CELL PROLIFERATION ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE CELL; ANTIBODY SPECIFICITY; AORTA; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; PHENOTYPE; SMOOTH MUSCLE CELL; VASCULAR SMOOTH MUSCLE;

ADULT; AORTA; ATHEROSCLEROSIS; BIOMARKERS; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; ORGAN SPECIFICITY; PHENOTYPE;

EID: 84961275894     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12825     Document Type: Article

References (47)

1. Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature. 2011; 473: 317-25.
2. Santovito D, Mandolini C, Marcantonio P, et al. Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients. Expert Opin Ther Targets. 2013; 17: 217-23.
3. Rensen SS, Doevendans PA, van Eys GJ. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J. 2007; 15: 100-8.
4. Hu B, Song JT, Qu HY, et al. Mechanical stretch suppresses microRNA-145 expression by activating extracellular signal-regulated kinase 1/2 and upregulating angiotensin-converting enzyme to alter vascular smooth muscle cell phenotype. PLoS ONE. 2014; 9: e96338.
5. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116: 281-97.
6. Friedman RC, Farh KK-H, Burge CB, et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009; 19: 92-105.
7. Boettger T, Beetz N, Kostin S, et al. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest. 2009; 119: 2634-47.
8. Li Y, Song Y-H, Li F, et al. MicroRNA-221 regulates high glucose-induced endothelial dysfunction. Biochem Biophys Res Commun. 2009; 381: 81-3.
9. Zhang C. MicroRNAs: role in cardiovascular biology and disease. Clin Sci (Lond). 2008; 114: 699-706.
10. Albinsson S, Suarez Y, Skoura A, et al. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Arterioscler Thromb Vasc Biol. 2010; 30: 1118-26.
11. Urbich C, Kuehbacher A, Dimmeler S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res. 2008; 79: 581-8.
12. Cheng Y, Liu X, Yang J, et al. MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res. 2009; 105: 158-66.
13. Ji R, Cheng Y, Yue J, et al. MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. Circ Res. 2007; 100: 1579-88.
14. Caruso P, Dempsie Y, Stevens HC, et al. A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples. Circ Res. 2012; 111: 290-300.
15. Hutcheson R, Terry R, Chaplin J, et al. MicroRNA-145 restores contractile vascular smooth muscle phenotype and coronary collateral growth in the metabolic syndrome. Arterioscler Thromb Vasc Biol. 2013; 33: 727-36.
16. Cordes KR, Sheehy NT, White MP, et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature. 2009; 460: 705-10.
17. Cipollone F, Felicioni L, Sarzani R, et al. A unique microRNA signature associated with plaque instability in humans. Stroke J Cereb Circ. 2011; 42: 2556-63.
18. Huang J, Cheng L, Li J, et al. Myocardin regulates expression of contractile genes in smooth muscle cells and is required for closure of the ductus arteriosus in mice. J Clin Invest. 2008; 118: 515-25.
19. Ross R, Wight TN, Strandness E, et al. Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery. Am J Pathol. 1984; 114: 79-93.
20. Mosse PR, Campbell GR, Wang ZL, et al. Smooth muscle phenotypic expression in human carotid arteries. I. Comparison of cells from diffuse intimal thickenings adjacent to atheromatous plaques with those of the media. Lab Invest. 1985; 53: 556-62.
21. Bennett MR, Evan GI, Schwartz SM. Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques. J Clin Invest. 1995; 95: 2266-74.
22. Bauriedel G, Hutter R, Welsch U, et al. Role of smooth muscle cell death in advanced coronary primary lesions: implications for plaque instability. Cardiovasc Res. 1999; 41: 480-8.
23. Bennett MR, Macdonald K, Chan SW, et al. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques. Circ Res. 1998; 82: 704-12.
24. Bonin LR, Madden K, Shera K, et al. Generation and characterization of human smooth muscle cell lines derived from atherosclerotic plaque. Arterioscler Thromb Vasc Biol. 1999; 19: 575-87.
25. Mulvihill ER, Jaeger J, Sengupta R, et al. Atherosclerotic plaque smooth muscle cells have a distinct phenotype. Arterioscler Thromb Vasc Biol. 2004; 24: 1283-9.
26. Gorenne I, Kavurma M, Scott S, et al. Vascular smooth muscle cell senescence in atherosclerosis. Cardiovasc Res. 2006; 72: 9-17.
27. Morrow D, Guha S, Sweeney C, et al. Notch and vascular smooth muscle cell phenotype. Circ Res. 2008; 103: 1370-82.
28. Mack CP. Signaling mechanisms that regulate smooth muscle cell differentiation. Arterioscler Thromb Vasc Biol. 2011; 31: 1495-505.
29. Halka AT, Turner NJ, Carter A, et al. The effects of stretch on vascular smooth muscle cell phenotype in vitro. Cardiovasc Pathol. 2008; 17: 98-102.
30. Song Jt, Hu B, Qu Hy, et al. Mechanical stretch modulates microRNA 21 expression, participating in proliferation and apoptosis in cultured human aortic smooth muscle cells. PLoS ONE. 2012; 7: e47657.
31. Barauna VG, Campos LCG, Miyakawa AA, et al. ACE as a mechanosensor to shear stress influences the control of its own regulation via phosphorylation of cytoplasmic Ser(1270). PLoS ONE. 2011; 6: e22803.
32. Muthiah M, Islam MA, Lee H-J, et al. MicroRNA delivery with osmotic polysorbitol-based transporter suppresses breast cancer cell proliferation. Int J Biol Macromol. 2015; 72: 1237-43.
33. Khan S, Ebeling MC, Zaman MS, et al. MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer. Oncotarget. 2014; 5: 7599-609.
34. Liu Y, Wu C, Wang Y, et al. MicroRNA-145 inhibits cell proliferation by directly targeting ADAM17 in hepatocellular carcinoma. Oncol Rep. 2014; 32: 1923-30.
35. Lei P, Xie J, Wang L, et al. microRNA-145 inhibits osteosarcoma cell proliferation and invasion by targeting ROCK1. Mol Med Rep. 2014; 10: 155-60.
36. Lee HK, Bier A, Cazacu S, et al. MicroRNA-145 is downregulated in glial tumors and regulates glioma cell migration by targeting connective tissue growth factor. PLoS ONE. 2013; 8: e54652.
37. Gregersen LH, Jacobsen AB, Frankel LB, et al. MicroRNA-145 targets YES and STAT1 in colon cancer cells. PLoS ONE. 2010; 5: e8836.
38. Hou Y, Wang X, Chen Y, et al. MicroRNA-145 as ideal biomarker for the diagnosis of various carcinomas. Tumour Biol. 2015; 36: 2641-9.
39. Cui S-Y, Wang R, Chen L-B. MicroRNA-145: a potent tumour suppressor that regulates multiple cellular pathways. J Cell Mol Med. 2014; 18: 1913-26.
40. Yuan W, Sui C, Liu Q, et al. Up-regulation of microRNA-145 associates with lymph node metastasis in colorectal cancer. PLoS ONE. 2014; 9: e102017.
41. Albinsson S, Sessa WC. Can microRNAs control vascular smooth muscle phenotypic modulation and the response to injury? Physiol Genomics. 2011; 43: 529-33.
42. Xin M, Small EM, Sutherland LB, et al. MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev. 2009; 23: 2166-78.
43. Vasudevan S, Tong Y, Steitz JA. Switching from repression to activation: microRNAs can up-regulate translation. Science. 2007; 318: 1931-4.
44. Wang Z, Wang D-Z, Hockemeyer D, et al. Myocardin and ternary complex factors compete for SRF to control smooth muscle gene expression. Nature. 2004; 428: 185-9.
45. Wang D, Chang PS, Wang Z, et al. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell. 2001; 105: 851-62.
46. Treisman R. Ternary complex factors: growth factor regulated transcriptional activators. Curr Opin Genet Dev. 1994; 4: 96-101.
47. Riches K, Alshanwani AR, Warburton P, et al. Elevated expression levels of miR-143/5 in saphenous vein smooth muscle cells from patients with Type 2 diabetes drive persistent changes in phenotype and function. J Mol Cell Cardiol. 2014; 74: 240-50.